^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PTGS2 positive + MET positive + TOPK positive + EGFR mutation

    i
    Other names: PTGS2, Prostaglandin-Endoperoxide Synthase 2, Prostaglandin G/H Synthase 2, Prostaglandin-Endoperoxide Synthase 2 (Prostaglandin G/H Synthase And Cyclooxygenase), Prostaglandin H2 Synthase 2, Cyclooxygenase 2, PGH Synthase 2, PGHS-2, PHS II, COX-2, COX2, Cyclooxygenase 2b, Cyclooxygenase-2, GRIPGHS, PGG/HS, HCox-2, PHS-2, DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase, PBK, PDZ Binding Kinase, T-LAK Cell-Originated Protein Kinase, Cancer/Testis Antigen 84, Nori-3, CT84, TOPK, SPK, Lymphokine-Activated Killer T-Cell-Originated Protein Kinase, Spermatogenesis-Related Protein Kinase, MAPKK-Like Protein Kinase, Serine/Threonine Protein Kinase, Epididymis Luminal Protein 164, PDZ-Binding Kinase, FLJ14385, HEL164,
    Entrez ID:
    4233; 5743; 55872
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    Associations
    News
    Trials